Marsden Healthcare Limited 06290234 false 2024-04-01 2025-03-31 2025-03-31 The principal activity of the company is operating residential care homes. Digita Accounts Production Advanced 6.30.9574.0 true true 06290234 2024-04-01 2025-03-31 06290234 2025-03-31 06290234 bus:Director1 1 2025-03-31 06290234 bus:Director2 1 2025-03-31 06290234 core:RetainedEarningsAccumulatedLosses 2025-03-31 06290234 core:ShareCapital 2025-03-31 06290234 core:CurrentFinancialInstruments 2025-03-31 06290234 core:CurrentFinancialInstruments core:WithinOneYear 2025-03-31 06290234 core:Non-currentFinancialInstruments 2025-03-31 06290234 core:Non-currentFinancialInstruments core:AfterOneYear 2025-03-31 06290234 core:Goodwill 2025-03-31 06290234 core:FurnitureFittingsToolsEquipment 2025-03-31 06290234 core:LandBuildings 2025-03-31 06290234 bus:SmallEntities 2024-04-01 2025-03-31 06290234 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 06290234 bus:FilletedAccounts 2024-04-01 2025-03-31 06290234 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 06290234 bus:RegisteredOffice 2024-04-01 2025-03-31 06290234 bus:Director1 2024-04-01 2025-03-31 06290234 bus:Director1 1 2024-04-01 2025-03-31 06290234 bus:Director2 2024-04-01 2025-03-31 06290234 bus:Director2 1 2024-04-01 2025-03-31 06290234 bus:Director3 2024-04-01 2025-03-31 06290234 bus:Director4 2024-04-01 2025-03-31 06290234 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 06290234 bus:Agent1 2024-04-01 2025-03-31 06290234 core:Goodwill 2024-04-01 2025-03-31 06290234 core:FurnitureFittings 2024-04-01 2025-03-31 06290234 core:FurnitureFittingsToolsEquipment 2024-04-01 2025-03-31 06290234 core:LandBuildings 2024-04-01 2025-03-31 06290234 core:OfficeEquipment 2024-04-01 2025-03-31 06290234 countries:EnglandWales 2024-04-01 2025-03-31 06290234 2024-03-31 06290234 bus:Director1 1 2024-03-31 06290234 bus:Director2 1 2024-03-31 06290234 core:Goodwill 2024-03-31 06290234 core:FurnitureFittingsToolsEquipment 2024-03-31 06290234 core:LandBuildings 2024-03-31 06290234 2023-04-01 2024-03-31 06290234 2024-03-31 06290234 bus:Director1 1 2024-03-31 06290234 bus:Director2 1 2024-03-31 06290234 core:RetainedEarningsAccumulatedLosses 2024-03-31 06290234 core:ShareCapital 2024-03-31 06290234 core:CurrentFinancialInstruments 2024-03-31 06290234 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 06290234 core:Non-currentFinancialInstruments 2024-03-31 06290234 core:Non-currentFinancialInstruments core:AfterOneYear 2024-03-31 06290234 core:FurnitureFittingsToolsEquipment 2024-03-31 06290234 core:LandBuildings 2024-03-31 06290234 bus:Director1 1 2023-04-01 2024-03-31 06290234 bus:Director2 1 2023-04-01 2024-03-31 06290234 bus:Director1 1 2023-03-31 06290234 bus:Director2 1 2023-03-31 iso4217:GBP xbrli:pure

Registration number: 06290234

Marsden Healthcare Limited

Unaudited Filleted Financial Statements

for the Year Ended 31 March 2025

 

Marsden Healthcare Limited

Contents

Company Information

1

Accountants' Report

2

Balance Sheet

3 to 4

Notes to the Unaudited Financial Statements

5 to 10

 

Marsden Healthcare Limited

Company Information

Directors

Mr D Jassal

Mr H Khanna

Mrs S Jassal

Mrs K K Khanna

Registered office

Rivendell
Langley Park Road
Iver
Buckinghamshire
SL0 0JQ

Accountants

Hargreaves Brown & Benson
Chartered Accountants
1 Bond Street
Colne
Lancashire
BB8 9DG

 

Chartered Accountants' Report to the Board of Directors on the Preparation of the Unaudited Statutory Accounts of
Marsden Healthcare Limited
for the Year Ended 31 March 2025

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of Marsden Healthcare Limited for the year ended 31 March 2025 as set out on pages 3 to 10 from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at
http://www.icaew.com/regulation.

This report is made solely to the Board of Directors of Marsden Healthcare Limited, as a body. Our work has been undertaken solely to prepare for your approval the accounts of Marsden Healthcare Limited and state those matters that we have agreed to state to the Board of Directors of Marsden Healthcare Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Marsden Healthcare Limited and its Board of Directors as a body for our work or for this report.

It is your duty to ensure that Marsden Healthcare Limited has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit of Marsden Healthcare Limited. You consider that Marsden Healthcare Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the accounts of Marsden Healthcare Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts.

......................................

Hargreaves Brown & Benson
Chartered Accountants
1 Bond Street
Colne
Lancashire
BB8 9DG

2 June 2025

 

Marsden Healthcare Limited

(Registration number: 06290234)
Balance Sheet as at 31 March 2025

Note

2025
£

2024
£

Fixed assets

 

Tangible assets

5

1,471,799

1,499,350

Current assets

 

Stocks

6

-

895

Debtors

7

410,451

278,652

Cash at bank and in hand

 

283,046

410,748

 

693,497

690,295

Creditors: Amounts falling due within one year

8

(229,195)

(249,131)

Net current assets

 

464,302

441,164

Total assets less current liabilities

 

1,936,101

1,940,514

Creditors: Amounts falling due after more than one year

8

(563,935)

(626,594)

Provisions for liabilities

(24,098)

(30,985)

Net assets

 

1,348,068

1,282,935

Capital and reserves

 

Called up share capital

200

200

Retained earnings

1,347,868

1,282,735

Shareholders' funds

 

1,348,068

1,282,935

 

Marsden Healthcare Limited

(Registration number: 06290234)
Balance Sheet as at 31 March 2025

For the financial year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 2 June 2025 and signed on its behalf by:
 

.........................................
Mr D Jassal
Director

.........................................
Mr H Khanna
Director

 

Marsden Healthcare Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Rivendell
Langley Park Road
Iver
Buckinghamshire
SL0 0JQ

These financial statements were authorised for issue by the Board on 2 June 2025.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Fixtures and Fittings

10% on cost

Equipment

25% on cost

 

Marsden Healthcare Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

Goodwill

Goodwill arising on the acquisition of an entity represents the excess of the cost of acquisition over the company’s interest in the net fair value of the identifiable assets, liabilities and contingent liabilities of the entity recognised at the date of acquisition. Goodwill is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is held in the currency of the acquired entity and revalued to the closing rate at each reporting period date. Goodwill is amortised over its useful life, which shall not exceed ten years if a reliable estimate of the useful life cannot be made.

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Asset class

Amortisation method and rate

Goodwill

12.5% to 20% on cost

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

 

Marsden Healthcare Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Leases

Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year was 54 (2024 - 50).

 

Marsden Healthcare Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

4

Intangible assets

Goodwill
 £

Total
£

Cost or valuation

At 1 April 2024

393,885

393,885

At 31 March 2025

393,885

393,885

Amortisation

At 1 April 2024

393,885

393,885

At 31 March 2025

393,885

393,885

Carrying amount

At 31 March 2025

-

-

5

Tangible assets

Land and buildings
£

Furniture, fittings and equipment
 £

Total
£

Cost or valuation

At 1 April 2024

1,375,409

599,352

1,974,761

Additions

-

11,662

11,662

At 31 March 2025

1,375,409

611,014

1,986,423

Depreciation

At 1 April 2024

-

475,411

475,411

Charge for the year

-

39,213

39,213

At 31 March 2025

-

514,624

514,624

Carrying amount

At 31 March 2025

1,375,409

96,390

1,471,799

At 31 March 2024

1,375,409

123,941

1,499,350

Included within the net book value of land and buildings above is £1,375,409 (2024 - £1,375,409) in respect of freehold land and buildings.
 

6

Stocks

2025
£

2024
£

Other inventories

-

895

 

Marsden Healthcare Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

7

Debtors

2025
£

2024
£

Trade debtors

20,604

33,825

Prepayments

19,827

12,073

Other debtors

370,020

232,754

410,451

278,652

8

Creditors

Creditors: amounts falling due within one year

Note

2025
£

2024
£

Due within one year

 

Loans and borrowings

9

62,659

62,659

Trade creditors

 

2,746

4,604

Taxation and social security

 

123,376

146,754

Accruals and deferred income

 

40,414

33,385

Other creditors

 

-

1,729

 

229,195

249,131

Creditors: amounts falling due after more than one year

Note

2025
£

2024
£

Due after one year

 

Loans and borrowings

9

563,935

626,594


 

 

Marsden Healthcare Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

9

Loans and borrowings

Non-current loans and borrowings

2025
£

2024
£

Bank borrowings

563,935

626,594

Current loans and borrowings

2025
£

2024
£

Bank borrowings

62,659

62,659

The bank borrowings are secured by a charge over the company’s assets.

10

Related party transactions

Transactions with directors

2025

At 1 April 2024
£

Advances to director
£

Repayments by director
£

At 31 March 2025
£

Mr D Jassal

90,003

151,233

(120,000)

121,236

Mr H Khanna

90,003

151,233

(120,000)

121,236

2024

At 1 April 2023
£

Advances to director
£

Repayments by director
£

At 31 March 2024
£

Mr D Jassal

19,615

200,388

(130,000)

90,003

Mr H Khanna

19,615

200,388

(130,000)

90,003